Literature DB >> 20939448

Drug-induced restless legs syndrome.

.   

Abstract

Restless legs syndrome can be very troublesome but it has no serious physical complications. The underlying causes are unknown, but it can be triggered or aggravated by a drug. In early 2010, about 60 cases of drug-induced restless legs syndrome had been published in detail. The drugs implicated were mainly psychotropics, especially antidepressants and neuroleptics. Some drugs used to treat restless legs syndrome, especially dopaminergic drugs, can in fact aggravate symptoms. Drug-induced restless legs syndrome generally resolves when the dose is reduced or the drug is withdrawn. Dysfunction of the dopaminergic system has been implicated in some cases. In practice, when a patient presents with restless legs syndrome, the role of a drug, especially a psychotropic, should be considered. Drug withdrawal or a dose reduction may be beneficial.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20939448

Source DB:  PubMed          Journal:  Prescrire Int        ISSN: 1167-7422


  3 in total

1.  Update on therapy for narcolepsy.

Authors:  Michael J Thorpy
Journal:  Curr Treat Options Neurol       Date:  2015-05       Impact factor: 3.598

2.  MAPT1 gene rs1052553 variant is unrelated with the risk for restless legs syndrome.

Authors:  Angela Roco; Félix Javier Jiménez-Jiménez; Hortensia Alonso-Navarro; Carmen Martínez; Martín Zurdo; Laura Turpín-Fenoll; Jorge Millán; Teresa Adeva-Bartolomé; Esther Cubo; Francisco Navacerrada; Ana Rojo-Sebastián; Lluisa Rubio; Marisol Calleja; José Francisco Plaza-Nieto; Belén Pilo-de-la-Fuente; Margarita Arroyo-Solera; Elena García-Martín; José A G Agúndez
Journal:  J Neural Transm (Vienna)       Date:  2012-09-22       Impact factor: 3.575

Review 3.  Restless Legs Syndrome: From Pathophysiology to Clinical Diagnosis and Management.

Authors:  Shiyi Guo; Jinsha Huang; Haiyang Jiang; Chao Han; Jie Li; Xiaoyun Xu; Guoxin Zhang; Zhicheng Lin; Nian Xiong; Tao Wang
Journal:  Front Aging Neurosci       Date:  2017-06-02       Impact factor: 5.750

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.